Evidence map›Paper›PMID 33595707›Full record

ArticleMedical microbiology and immunology2021

Evaluation of 5 commercial assays for the detection of Mycoplasma genitalium and other Urogenital Mycoplasmas.

Prenilla Naidu, Sandy Shokoples, Irene Martin, Nathan Zelyas, Ameeta Singh

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Prenilla NaiduProvincial Laboratory for Public Health (ProvLab), Alberta Precision Laboratories, Edmonton, Alberta, Canada. prenilla@ualberta.ca.ORCID http://orcid.org/0000-0002-7028-098X
Sandy ShokoplesProvincial Laboratory for Public Health (ProvLab), Alberta Precision Laboratories, Edmonton, Alberta, Canada.
Irene MartinNational Microbiology Laboratory, Winnipeg, Canada.
Nathan ZelyasProvincial Laboratory for Public Health (ProvLab), Alberta Precision Laboratories, Edmonton, Alberta, Canada.
Ameeta SinghDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
University of Alberta · CAProvincial Laboratory of Public Health · CAUniversity of Alberta Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The focus on urogenital mycoplasmas as the possible etiologic agents of urogenital infections and syndromes, has increased in the last decade. Of these, Mycoplasma genitalium is proven to be pathogenic and sexually transmitted. We compared five commercially available assays for the detection of these organisms in urogenital mycoplasma culture specimen remnants. Stored specimen remnants were tested on Aptima Mycoplasma genitalium, Allplex™ STI Essential and CGMT, ResitancePlus

Indexed as

FemaleHumansLimit of DetectionMaleMolecular Diagnostic TechniquesMycoplasmaMycoplasma genitaliumMycoplasma InfectionsReagent Kits, DiagnosticSensitivity and SpecificityReagent Kits, DiagnosticMacrolide resistanceMycoplasma genitaliumUrogenital mycoplasmas

Identifiers

PMID33595707
OpenAlexW3133471801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.